PAPNET-Assisted Rescreening of Cervical Smears
Authors:
- Timothy J. O'LearyTOTimothy J. O'Leary
- Miguel TelladoMTMiguel Tellado
- Sally-Beth BucknerSBSally-Beth Buckner
- Izzat S. AliIAIzzat S. Ali
- Angelica StevensASAngelica Stevens
- Curtis W. OllayosCOCurtis W. Ollayos
Open Access
- 21 January 1998
- journal article
- toward optimal-laboratory-use
- Published by American Medical Association (AMA) in JAMA
- Vol. 279 (3) , 235-237
Abstract
ALTHOUGH the Papanicolaou (Pap) smear has contributed to a significant decrease in cervical cancer mortality, conventional cytologic examination misses a significant number of premalignant lesions in which diagnostic cells are present on the slide. Among the tools that are available for reducing the false-negative rate are automated rescreening devices that have been approved recently by the Food and Drug Administration.1-4Keywords
This publication has 9 references indexed in Scilit:
- Consequences of neural network technology for cervical screening: Increase in diagnostic consistency and positive scoresCancer, 1996
- The FDA Review Process: Obtaining Premarket Approval for the PAPNET Testing SystemActa Cytologica, 1996
- Computer-Assisted Quality AssuranceActa Cytologica, 1996
- Opinion Poll on Quality Assurance and Quality ControlActa Cytologica, 1996
- Assessing the Costs and Benefits of Alternative Rescreening StrategiesActa Cytologica, 1996
- Efficacy of automated cervical cytology screeningDiagnostic Cytopathology, 1995
- Evaluation of the PAPNET™Cytologic Screening System for Quality Control of Cervical SmearsAmerican Journal of Clinical Pathology, 1994
- Neural network processing can provide means to catch errors that slip through human screening of pap smearsDiagnostic Cytopathology, 1993
- What Do We Gain from the Sixth Stool Guaiac?New England Journal of Medicine, 1975